Genomma Lab stock: Genomma Lab schedules October 21 results. Analysts rate Genomma Lab stock Buy

Genomma Lab is scheduled to report its third-quarter 2026 results on October 21, 2026, after the Mexican Stock Exchange closes, according to Yahoo Finance. The company also scheduled a results conference call for October 22, 2026. Genomma Lab stock was trading at EUR 0.69 at Lang & Schwarz on October 20, 2026 at 4:36 p.m. CEST.

Revenue estimates point higher

finanzen.net reported on October 6, 2026 that seven analysts forecast fiscal-year 2026 revenue of MXN 17.80 billion, compared with MXN 17.54 billion in fiscal year 2025. That is a 1.48 percent increase. The same estimate set put earnings per share at MXN 1.95, versus MXN 1.65 in the prior fiscal year.

What does the forecast imply?

The immediate test is the third quarter ended September 30, 2026. One analyst forecast revenue of MXN 4.57 billion, compared with MXN 4.44 billion in the year-earlier quarter, a 2.93 percent increase, according to finanzen.net. The available Q2 2026 figures provide a tougher comparison: revenue was MXN 4,397.04 million and net income was MXN 374.49 million, according to Investing.com.

Results and conference call dates

The October 21 release is due after the BMV close, while management is scheduled to discuss the figures on October 22 at 11:00 a.m. Mexico City time. Genomma Lab develops and markets over-the-counter pharmaceutical and personal care products across Mexico and international markets.

Price stays below one euro

Genomma Lab stock was trading at EUR 0.69 at Lang & Schwarz on October 20, 2026 at 4:36 p.m. CEST. The quote gives investors a clear euro reference ahead of the results release, while the operating figures remain the more important near-term test.

The further course of trading is shown by the continuously updated real-time quote of Genomma Lab stock.

Market context: Current market reports.

More news and analyses on Genomma Lab stock